Delhi, India

Dinesh Puri

This inventor holds 1 USPTO granted patent. Top assignee: Diakron Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dinesh Puri. Retrieved from https://idiyas.com/inventor/dinesh-puri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dinesh Puri: Innovator in Anti-Diabetic and Cholesterol-Lowering Preparations

Introduction

Dinesh Puri is a notable inventor based in Delhi, India. He has made significant contributions to the field of health and nutrition through his innovative research. His work primarily focuses on developing natural compositions that aid in managing diabetes and cholesterol levels.

Latest Patents

Dinesh Puri holds a patent for an "Anti-diabetic and cholesterol lowering preparation from fenugreek seeds." This invention relates to a composition that exhibits blood glucose-lowering and cholesterol-lowering activity derived from seeds of the Papilinaceae Leguminosae family, specifically fenugreek seeds. The patent outlines methods for obtaining the composition from the seeds and their parts. Additionally, it includes therapeutic methods for using the composition to treat diabetes and hypercholesterolemia.

Career Highlights

Dinesh Puri is currently associated with Diakron Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceuticals. His dedication to research and development has positioned him as a key player in the industry.

Collaborations

Dinesh has collaborated with notable colleagues, including Pothapragada Suryanarayana Murthy and Radha Moorthy. These collaborations have further enhanced his research and development efforts.

Conclusion

Dinesh Puri's contributions to the field of health through his innovative patent demonstrate his commitment to improving the quality of life for individuals managing diabetes and cholesterol issues. His work continues to inspire future innovations in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…